Ascentage Pharma Group International (ASPHF)
USD 2.69
(0.0%)
USD 2.69
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 221.98 Million CNY | 5.85% |
| 2022 | 209.71 Million CNY | 651.38% |
| 2021 | 27.91 Million CNY | 124.18% |
| 2020 | 12.45 Million CNY | -14.21% |
| 2019 | 14.51 Million CNY | 113.21% |
| 2018 | 6.8 Million CNY | 7.57% |
| 2017 | 6.32 Million CNY | -17.46% |
| 2016 | 7.66 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q3 | 5.42 Million USD | -44.79% |
| 2023 Q4 | 5.58 Million USD | 2.86% |
| 2023 Q1 | 10.38 Million USD | 25.77% |
| 2023 FY | 221.98 Million CNY | 5.85% |
| 2023 Q2 | 9.83 Million USD | -5.35% |
| 2022 Q4 | 8.26 Million USD | 3.16% |
| 2022 Q2 | 14.73 Million USD | 0.0% |
| 2022 FY | 209.71 Million CNY | 651.38% |
| 2022 Q3 | 8 Million USD | -45.64% |
| 2021 Q2 | 2 Million USD | 0.0% |
| 2021 FY | 27.91 Million CNY | 124.18% |
| 2021 Q4 | 2.31 Million USD | 0.0% |
| 2020 FY | 12.45 Million CNY | -14.21% |
| 2020 Q2 | 372 Thousand USD | 0.0% |
| 2020 Q4 | 1.45 Million USD | 0.0% |
| 2019 Q2 | 342.8 Thousand USD | 0.0% |
| 2019 Q4 | 1.74 Million USD | 0.0% |
| 2019 FY | 14.51 Million CNY | 113.21% |
| 2018 FY | 6.8 Million CNY | 7.57% |
| 2017 FY | 6.32 Million CNY | -17.46% |
| 2016 FY | 7.66 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -289088.52% |
| CSL Limited | 14.69 Billion USD | 98.489% |
| Eiger BioPharmaceuticals, Inc. | 15.77 Million USD | -1307.367% |
| Nanobac Pharmaceuticals, Incorporated | 17.62 Thousand USD | -1259669.593% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| Evofem Biosciences, Inc. | 18.21 Million USD | -1118.487% |
| Santhera Pharmaceuticals Holding AG | 122.95 Million USD | -80.543% |
| Propanc Biopharma, Inc. | - USD | -Infinity% |
| Mesoblast Limited | 5.9 Million USD | -3661.166% |
| Marizyme, Inc. | 645.81 Thousand USD | -34272.958% |
| Genus plc | 668.8 Million USD | 66.809% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -54020.659% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| ContraFect Corporation | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| IMV Inc. | - USD | -Infinity% |
| AXIM Biotechnologies, Inc. | 39.51 Thousand USD | -561628.832% |
| MultiCell Technologies, Inc. | 49.32 USD | -450089113.301% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 49.72 Million USD | -346.459% |
| EV Biologics, Inc. | 48.9 Thousand USD | -453855.01% |
| Q BioMed Inc. | 284.35 Thousand USD | -77966.622% |
| Emmaus Life Sciences, Inc. | 29.59 Million USD | -650.022% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -317020.0% |
| Skye Bioscience, Inc. | - USD | -Infinity% |
| SQZ Biotechnologies Company | 21.47 Million USD | -933.541% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | 75.72 Thousand USD | -293048.804% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -337631.256% |
| Acro Biomedical Co., Ltd. | 658.5 Thousand USD | -33610.554% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 245.31 Million USD | 9.511% |
| Therapeutic Solutions International, Inc. | 98.99 Thousand USD | -224139.853% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| GB Sciences, Inc. | - USD | -Infinity% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| argenx SE | 1.22 Billion USD | 81.898% |
| HST Global, Inc. | - USD | -Infinity% |
| Halberd Corporation | 999.00 USD | -22220520.621% |
| Enzolytics Inc. | 52.79 Thousand USD | -420356.095% |
| Resverlogix Corp. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 608.52 Thousand USD | -36379.027% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 1.93 Million USD | -11389.855% |
| American Oriental Bioengineering, Inc. | 145.09 Million USD | -52.987% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Provectus Biopharmaceuticals, Inc. | 557.71 Thousand USD | -39702.765% |
| Endonovo Therapeutics, Inc. | 140.24 Thousand USD | -158186.391% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -35855.58% |
| ONE Bio Corp. | 52.29 Million USD | -324.474% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 839.52 Million USD | 73.559% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | - USD | -Infinity% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | - USD | -Infinity% |
| Helix BioMedix, Inc. | 997.72 Thousand USD | -22148.994% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 48.35 Million USD | -359.081% |
| BioStem Technologies, Inc. | 16.68 Million USD | -1230.408% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -93738.35% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -93738.35% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Affymax, Inc. | 1.36 Million USD | -16115.047% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| CytoDyn Inc. | - USD | -Infinity% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 473.73 Thousand USD | -46758.759% |
| SYBLEU INC | 11.69 Thousand USD | -1897848.016% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| International Stem Cell Corporation | 7.78 Million USD | -2749.968% |
| Bioxytran, Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 13 Thousand USD | -1707469.231% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | - USD | -Infinity% |
| Neutra Corp. | 39.53 Thousand USD | -561401.492% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| PureTech Health plc | 3.33 Million USD | -6566.186% |
| Coeptis Therapeutics, Inc. | - USD | -Infinity% |
| IXICO plc | 6.66 Million USD | -3230.593% |
| IntelGenx Technologies Corp. | 1.03 Million USD | -21265.159% |
| Gelesis Holdings, Inc. | 25.76 Million USD | -761.505% |
| CSL Limited | 14.8 Billion USD | 98.5% |
| Cellectis S.A. | 755 Thousand USD | -29301.854% |